News
COVID, Moderna and FDA
Digest more
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...
As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future of vaccine development in the U.S. faces growing challenges, including ...
Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...
CompanyOverview\|NASDAQ:MRNA] Moderna Inc. (NASDAQ: MRNA) is down 35% in 2025, making it one of the worst-performing stocks ...
11d
News-Medical.Net on MSNHIV vaccine study marks breakthrough in targeting broad immune responsesA decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results